Sustained Immunoparalysis in Endotoxin-Tolerized Monocytic Cells.


Journal

Mediators of inflammation
ISSN: 1466-1861
Titre abrégé: Mediators Inflamm
Pays: United States
ID NLM: 9209001

Informations de publication

Date de publication:
2020
Historique:
received: 11 02 2020
revised: 05 05 2020
accepted: 11 05 2020
entrez: 4 7 2020
pubmed: 4 7 2020
medline: 8 6 2021
Statut: epublish

Résumé

Sepsis is associated with a strong inflammatory reaction triggering a complex and prolonged immune response. Septic patients have been shown to develop sustained immunosuppression due to a reduced responsiveness of leukocytes to pathogens. Changes in cellular metabolism of leukocytes have been linked to this phenomenon and contribute to the ongoing immunological derangement. However, the underlying mechanisms of these phenomena are incompletely understood. In cell culture models, we mimicked LPS tolerance conditions to provide evidence that epigenetic modifications account for monocyte metabolic changes which cause immune paralysis in restimulated septic monocytes. In detail, we observed differential methylation of CpG sites related to metabolic activity in human PBMCs 18 h after septic challenge. The examination of changes in immune function and metabolic pathways was performed in LPS-tolerized monocytic THP-1 cells. Passaged THP-1 cells, inheriting initial LPS challenge, presented with dysregulation of cytokine expression and oxygen consumption for up to 7 days after the initial LPS treatment. Proinflammatory cytokine concentrations of TNF

Identifiants

pubmed: 32617075
doi: 10.1155/2020/8294342
pmc: PMC7306843
doi:

Substances chimiques

Endotoxins 0
Lipopolysaccharides 0
NAD 0U46U6E8UK
Lactic Acid 33X04XA5AT
Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8294342

Informations de copyright

Copyright © 2020 Christina K. Weisheit et al.

Déclaration de conflit d'intérêts

None is declared.

Références

Lancet Infect Dis. 2013 Mar;13(3):260-8
pubmed: 23427891
Nat Rev Mol Cell Biol. 2009 Mar;10(3):192-206
pubmed: 19234478
J Immunol. 2003 Jan 1;170(1):508-19
pubmed: 12496438
Am J Respir Crit Care Med. 2007 Apr 15;175(8):763-7
pubmed: 17255558
J Immunol. 2011 Jun 15;186(12):7243-54
pubmed: 21576504
Epigenetics. 2011 Mar;6(3):273-83
pubmed: 21048427
Cell Res. 2015 Jul;25(7):771-84
pubmed: 26045163
Crit Care Med. 2020 Apr;48(4):459-465
pubmed: 32205591
Trends Immunol. 2009 Oct;30(10):475-87
pubmed: 19781994
PLoS One. 2019 Sep 27;14(9):e0222614
pubmed: 31560702
J Biol Chem. 2008 Nov 21;283(47):32198-208
pubmed: 18809684
BMC Genomics. 2018 Apr 25;19(1):290
pubmed: 29695247
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Front Immunol. 2018 Nov 20;9:2705
pubmed: 30515175
Nat Rev Immunol. 2013 Dec;13(12):862-74
pubmed: 24232462
Ann Transl Med. 2016 Nov;4(21):438
pubmed: 27942529
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Front Immunol. 2018 Oct 30;9:2498
pubmed: 30425714
Immunity. 2014 Jan 16;40(1):66-77
pubmed: 24412613
EMBO Mol Med. 2018 Aug;10(8):
pubmed: 29976786
Shock. 2000 Aug;14(2):128-33
pubmed: 10947155
Cytokine Growth Factor Rev. 2011 Aug;22(4):189-95
pubmed: 22019906
J Biol Chem. 2016 Jan 1;291(1):1-10
pubmed: 26534957
Cell. 2020 Mar 19;180(6):1044-1066
pubmed: 32164908
J Leukoc Biol. 2019 Jul;106(1):11-25
pubmed: 31169935
J Negat Results Biomed. 2016 Apr 25;15:9
pubmed: 27109115
Cell Host Microbe. 2016 May 11;19(5):579-82
pubmed: 27173925
Nat Rev Immunol. 2015 Jan;15(1):7-17
pubmed: 25534619
Ann N Y Acad Sci. 2020 Mar 23;:
pubmed: 32202669
Science. 2014 Sep 26;345(6204):1250684
pubmed: 25258083
Trends Genet. 2012 Mar;28(3):118-27
pubmed: 22226176
Crit Care. 2006;10(5):233
pubmed: 17044947
Microbes Infect. 2002 Jul;4(9):903-14
pubmed: 12106783
Nat Immunol. 2016 Apr;17(4):406-13
pubmed: 26950237
Mediators Inflamm. 2013;2013:697972
pubmed: 23818743
J Leukoc Biol. 2017 Jan;101(1):107-119
pubmed: 27780875
Clin Vaccine Immunol. 2014 Apr;21(4):534-45
pubmed: 24521784
Nature. 2018 Jul;559(7712):114-119
pubmed: 29950719
J Leukoc Biol. 2019 Feb;105(2):215-228
pubmed: 30633362
Antioxid Redox Signal. 2016 Nov 10;25(14):758-774
pubmed: 26983461
Front Immunol. 2018 Feb 19;9:270
pubmed: 29520272

Auteurs

Christina K Weisheit (CK)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany.

Alexandra Klüners (A)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany.

Lennart Wild (L)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany.

Alexandra Casalter (A)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany.

Stefanie Heilmann-Heimbach (S)

Department of Genomics, Life & Brain Center, Institute of Human Genetics, University of Bonn, Germany.

Sugirthan Sivalingam (S)

Department of Genomics, Life & Brain Center, Institute of Human Genetics, University of Bonn, Germany.

Jan L Kleiner (JL)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany.

Stefan F Ehrentraut (SF)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany.

Andreas Hoeft (A)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany.

Stilla Frede (S)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany.

Heidi Ehrentraut (H)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH